ClinicalTrials.gov
public full text
Public Domain
Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
A randomized, controlled pilot trial to evaluate the efficacy and safety of subcutaneous Abatacept in treating interstitial lung disease associated with the anti-synthetase syndrome.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Familial pulmonary alveolar proteinosis and type I interferonopathy by mutation of STAT2 (TIMS2)#475981
- A Method to Optimize Mecanical In-exsufflation in Neuromuscular Diseases#912694
- Genetic and Immunologic Characterization of IEI#1074407
- A Real-World Study of IBI351 for KRAS G12C+ NSCLC in China#1126299
- Study of M5049 in DM and PM Participants (NEPTUNIA)#916758
Record · ID 904706
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive